You are on page 1of 1

51664 Federal Register / Vol. 72, No.

174 / Monday, September 10, 2007 / Notices

the payroll system, and updating the suspects or has confirmed that the may file comments or objections to the
applicable routine uses. security or confidentiality of issuance of the proposed registration
In accordance with 5 U.S.C. 552a(e)(4) information in the system of records has and may, at the same time, file a written
and (11) the public is given a 30-day been compromised; (2) the Department request for a hearing on such
period in which to comment; and the has determined that as a result of the application pursuant to 21 CFR 1301.43
Office of Management and Budget suspected or confirmed compromise and in such form as prescribed by 21
(OMB), which has oversight there is a risk of harm to economic or CFR 1316.47.
responsibility under the Privacy Act, property interests, identity theft or Any such comments or objections
requires a 40-day period in which to fraud, or harm to the security or being sent via regular mail should be
conclude its review of the system. integrity of this system or other systems addressed, in quintuplicate, to the Drug
Therefore, please submit any comments or programs (whether maintained by the Enforcement Administration, Office of
by October 22, 2007. The public, OMB Department or another agency or entity) Diversion Control, Federal Register
and the Congress are invited to submit that rely upon the compromised Representative (ODL), Washington, DC
any comments to Joo Chung, Counsel, information; and (3) the disclosure 20537, or any being sent via express
Privacy and Civil Liberties Office, Office made to such agencies, entities, and mail should be sent to Drug
of the Deputy Attorney General, 950 persons is reasonably necessary to assist Enforcement Administration, Office of
Pennsylvania Ave., NW., Washington, in connection with the Department’s Diversion Control, Federal Register
DC 20530, facsimile number 202–616– efforts to respond to the suspected or Representative (ODL), 2401 Jefferson-
9627. confirmed compromise and prevent, Davis Highway, Alexandria, Virginia
In accordance with 5 U.S.C. 552a(r), minimize or remedy such harm. 22301; and must be filed no later than
the Department has provided a report to * * * * * October 10, 2007.
OMB and the Congress. [DELETE THE GENERAL SERVICES This procedure is to be conducted
ADMINISTRATION FROM ROUTINE simultaneously with and independent
Dated: September 4, 2007.
USE O, TO READ AS FOLLOWS.] of the procedures described in 21 CFR
Lee J. Lofthus, 1301.34(b), (c), (d), (e) and (f). As noted
O. To the National Archives and
Assistant Attorney General for in a previous notice published in the
Administration. Records Administration for purposes of
records management inspections Federal Register on September 23, 1975,
JUSTICE/JMD–003 conducted under the authority of 44 (40 FR 43745–46), all applicants for
U.S.C. 2904 and 2906. registration to import a basic class of
SYSTEM NAME: any controlled substance listed in
* * * * *
Department of Justice Payroll System, schedule I or II are, and will continue
Justice/JMD–003. [FR Doc. E7–17754 Filed 9–7–07; 8:45 am] to be required to demonstrate to the
BILLING CODE 4410–CP–P Deputy Assistant Administrator, Office
* * * * *
of Diversion Control, Drug Enforcement
CATEGORIES OF INDIVIDUALS COVERED BY THE Administration, that the requirements
SYSTEM: DEPARTMENT OF JUSTICE for such registration pursuant to 21
Current and former DOJ employees. U.S.C. 958(a), 21 U.S.C. 823(a), and 21
* * * * * Drug Enforcement Administration CFR 1301.34(b), (c), (d), (e) and (f) are
Importer of Controlled Substances; satisfied.
ROUTINE USES OF RECORDS MAINTAINED IN THE
SYSTEM, INCLUDING CATEGORIES OF USERS AND Notice of Application Dated: August 28, 2007.
THE PURPOSES OF SUCH USES: Joseph T. Rannazzisi,
Pursuant to 21 U.S.C. 958(i), the
* * * * * Deputy Assistant Administrator, Office of
Attorney General shall, prior to issuing Diversion Control, Drug Enforcement
[CHANGE THE SECOND a registration under this section to a
INTRODUCTORY PARAGRAPH TO Administration.
bulk manufacturer of a controlled [FR Doc. E7–17766 Filed 9–7–07; 8:45 am]
READ AS FOLLOWS.] substance in schedule I or II and prior
In accordance with an interagency to issuing a regulation under 21 U.S.C.
BILLING CODE 4410–09–P
agreement, as provided for in Office of 952(a)(2) authorizing the importation of
Management and Budget (OMB) such a substance, provide
implementing guidelines (40 FR 28948), DEPARTMENT OF JUSTICE
manufacturers holding registrations for
the DOJ may disclose records to the U.S. the bulk manufacture of the substance Drug Enforcement Administration
Department of Agriculture (USDA), an opportunity for a hearing.
National Finance Center (NFC), in order Therefore, in accordance with Title 21 Manufacturer of Controlled
to effect all financial transactions on Code of Federal Regulations (CFR), Substances; Notice of Registration
behalf of the DOJ related to employee 1301.34(a), this is notice that on July 19,
pay. By Notice dated May 10, 2007, and
2007, CIMA Labs, Inc., 7325 Aspen published in the Federal Register on
* * * * * Lane, Brooklyn Park, Minnesota 55428,
[CORRECT ROUTINE USE C, TO May 18, 2007, (72 FR 28073), Cody
made application by letter to the Drug Laboratories, Inc., 601 Yellowstone
READ AS FOLLOWS.] Enforcement Administration (DEA) to
C. To State and local courts of Avenue, Cody, Wyoming 82414, made
be registered as an importer of Nabilone application by renewal to the Drug
competent jurisdiction for the (7379), a basic class of controlled
enforcement of child support, alimony, Enforcement Administration (DEA) to
substance listed in schedule II. be registered as a bulk manufacturer of
or both, pursuant to 42 U.S.C. 659. The company plans to import the the basic classes of controlled
* * * * * basic class of controlled substance for
ebenthall on PRODPC61 with NOTICES

substances listed in schedule I and II:


[DELETE ROUTINE USE G AND clinical trials and research.
SUBSTITUTE THE FOLLOWING Any bulk manufacturer who is Drug Schedule
ROUTINE USE.] presently, or is applying to be,
G. To appropriate agencies, entities, registered with DEA to manufacture Dihydromorphine (9145) ............... I
and persons when (1) The Department such basic class of controlled substance Amphetamine (1100) .................... II

VerDate Aug<31>2005 15:27 Sep 07, 2007 Jkt 211001 PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\10SEN1.SGM 10SEN1

You might also like